68
CanSino Biologics Inc.
688185.SS · SHH
¥63.57 -2.34% (-¥1.52)
1M +12.34%
Market Cap ¥11.9B
P/E Ratio 292.24x
Div. Yield -
ROE 0.82%
Piotroski F-Score Strong
7/9Valuation
12 /100
Expensive P/E 292.24x
EV/EBITDA 60.02x
P/S 9.61x
Growth
19 /100
Declining Rev. growth 1.06%
Book val. growth 9.93%
EPS growth N/A
Profitability
27 /100
Weak Gross margin 72.43%
Net margin 3.29%
Op. margin 1.02%
Quality
4 /100
Poor ROIC 0.18%
ROE 0.82%
ROA 0.59%
Debt
80 /100
Low Debt/Equity 0.20x
Current ratio 4.39x
Int. coverage 0.14x
Stability
18 /100
Unstable Beta 1.22x
Rev. volatility 101.40%
EPS volatility 90.50%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 688185.SS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Xue Feng Yu
Employees
1,134
Headquarters
Tianjin
Evenimente viitoare
02 NOV.
Earnings
Upcoming earnings report